Evaluation of adherence to antiretroviral therapy in Italian HIV patients

AIDS Patient Care and STDs

Volumn 17, Issue 1, 2003, Pages 33-41

  Dorz, Stella ^a   Lazzarini, Luca ^b   Cattelan, Annamaria ^c   Meneghetti, Francesco ^c   Novara, Caterina ^a   Concia, Ercole ^b   Sica, Claudio ^a   Sanavio, Ezio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DOCTOR PATIENT RELATION; DRUG BLOOD LEVEL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SIDE EFFECT; SOCIAL PSYCHOLOGY;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INTERVIEWS; ITALY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 12244259050     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729103321042890     Document Type: Article

References (44)

1. Flexner C. HIV-1 protease inhibitors. N Engl J Med 1998;333:1281-1291.
2. Carpenter CCJ, Fisch MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1997: Updated recommendations of the International AIDS Society - USA panel. JAMA 1997;277:1962-1969.
3. Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. JAMA 1997;278:63-65.
4. Condra JH, Schleif WA, Blahy OM, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 1995;374:569-571.
5. Jacobsen H, Hanggi M, Ott M, et al. In vivo resistance to an HIV-1 protease inhibitor: Mutations, kinetics and frequencies. J Infect Dis 1996;173:1379-1387.
6. Vanhove G, Shapiro J, Winters M, Merigan T, Blaschke T. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA 1997;276:1955-1956.
7. Sackett DL, Snow JS. The magnitude of compliance and noncompliance. In: Haynes RB, Taylor DW, Sackett DI, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979:11-22.
8. Finnerty FA, Shaw LW, Himmelsbach CK. Hypertension in the inner city. II. Detection and follow-up. Circulation 1973;47:76-78.
9. Wilber JA, Barrow JG. Hypertension: A community problem. Am J Med 1972;52:653-656.
10. McKenny JM, Slining JM, Henderson HR, Devines D, Barr M. The effect on clinical pharmacy services on patients with essential hypertension. Circulation 1973;48:1104-1111.
11. Rudnick KV, Sackett DL, Hirst S. Hypertension in a family practice. Can Med Assoc J 1977;117:492-497.
12. Samuels JE, Hendrix J, Hilton M, Marantz PR, Sloan V, Small CB. Zidovudine therapy in an inner city population. J Acquir Immune Defic Syndr 1990;3:877-883.
13. Samet JH, Libman H, Steger KA, et al. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic. Am J Med 1992;92:495-502.
14. Broers B, Morabia A, Hirschel B. A cohort study of drug users' compliance with zidovudine treatment. Arch Intern Med 1994;154:1121-1127.
15. Cramer JA, Mattosn RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989;261:3273-3277.
16. Eldred LJ, Wu AW, Chaisson RE, Moore RD. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:117-125.
17. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E. Dosage frequency and drug-compliance behaviour: A comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991;41:589-592.
18. Haynes RB. Determinants of compliance: the disease and the mechanics of treatment. In: Haynes RB, Taylor DW, Sackett DI, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press, 1979:46-62.
19. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994;330:763-768.
20. Rand CS, Wise RA. Measuring adherence to asthma medication regiments. Am J Respir Care Med 1994;149:569-576.
21. Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theretically based approach. J Person Soc Psychol 1989;5:267-283.
22. Sica C, Novara C, Dorz S, Sanavio E. Coping Orientation to Problems Experienced (COPE). Bollettino di Psicologia Applicata 1997;223:25-34.
23. Carretero M, Burgess AP, Soler P, Soler M. Reliability and validity of an HIV-specific health-related quality of life measure for use with injecting drug users. AIDS 1996;10:1699-1705.
24. Marsh KC, Eiden E, McDonald E. Determination of ritonavir, a new HIV protease inhibitor, in biological sample using a reverse-phase high-performance liquid chromatography. J Chromatogr 1997;704:307-313.
25. Murri R, Ammassari A, Gallicano K, et al. Patient reported nonadherence to HAART is related to protease inhibitor levels. J Acquir Immun Def Syndr 2000;24:123-128.
26. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS 1997;11:1665-1670.
27. Lerner BH, Gulick A, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med 1998;129:573-578.
28. Besche CL, Collins G, Morse E, Simon P. Cofactors associated with partecipant compliance in two CPCRA trials. [Abstract No. B7040] International Conference on AIDS 1992;8.
29. Cortese L, Chung R, Stoute J, Oster C, Mansfield J, Ledsky R. Zidovudine usage: patient compliance and factors [Abstract No. PO-332-2233] International Conference on AIDS 1993;9:507.
30. LoCaputo S, Maggi P, Buccoliero G, Federico M, Angarano G, Pastore G. Antiretroviral therapy with zidovudine (AZT) [Abstract No. PO-B26-2124]. International Conference on AIDS 1993;9:489.
31. Muma RD, Ross WW, Parcel GC, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care 1995;7:439-448.
32. Singh N, Squier C, Sivek C, Wagener M, Hong Nguyen M, Yu VL. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: A prospective assessment with implications for enhancing compliance. AIDS Care 1996;8:261-269.
33. Stone VE, Hogan JW, Schuman P, et al. Antiretroviral regiment complexity, self-reported adherence, and HIV patients' understanding of their regiments: Survey of women in the HER study. J Acquir Immune Defic Syndr 2001;28:124-131.
34. Mostashari F, Riley E, Selwyn PL, Altice FL. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J AIDS 1998;18:34-38.
35. Besch LC. Compliance in clinical trials. AIDS 1995;9:1-10.
36. Sumartojo E. When tubercolosis treatment fails. A social behavior account of patient adherence. Am Rev Respir Dis 1993;147:1311-1320.
37. Ng JJ, Rosen RK, Malcolm SE, et al. Adherence to highly active antiretroviral therapy in substance abusers with HIV/AIDS [abstract 38]. J Gen Intern Med 2000;15:164.
38. Chesney MA, Ickovics JR, Chambers DB, et al. Self-report adherence to antiretroviral medications among partecipants in HIV clinical trial: The AACTG adherence instruments. AIDS Care 2000;12:255-266.
39. Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adhrence [abstract 98]. 6th Conference on Retroviruses and Opportunistics Infections, Chicago, January 31-February 4, 1999.
40. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practitioners Guidebook. New York: Plenum Press, 1987.
41. Bartlett JA, Demasi, R, Quinn J, et al. Overview of the effectiveness of triple-combination therapy in antiretroviral-naive HIV-1-infected adults. AIDS 2001;15:1369-1377.
42. Bartlett JA. Addressing the challenges of adherence. J AIDS 2001;29:2-10.
43. Stryker J, Coates TJ, DeCarlo P, Haynes-Sonstad K, Shriver M, Makadow HJ. Prevention of HIV. Looking back, looking ahead. JAMA 1994;273:1143-1148.
44. Zenilman JM, Erickson B, Fox MS, Reichart C, Hook EM. Effect of HIV posttest counseling on STD incidence. JAMA 1992;267:843-845.